Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio Total Return Level : 16.80 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 16.80 |
| August 21, 2026 | 16.83 |
| August 20, 2026 | 16.60 |
| August 19, 2026 | 17.00 |
| August 18, 2026 | 16.77 |
| August 17, 2026 | 17.00 |
| August 14, 2026 | 16.99 |
| August 13, 2026 | 16.96 |
| August 12, 2026 | 16.59 |
| August 11, 2026 | 16.38 |
| August 10, 2026 | 16.61 |
| August 07, 2026 | 16.16 |
| August 06, 2026 | 16.19 |
| August 05, 2026 | 16.14 |
| August 04, 2026 | 15.96 |
| August 03, 2026 | 15.95 |
| July 31, 2026 | 15.93 |
| July 30, 2026 | 16.07 |
| July 29, 2026 | 15.96 |
| July 28, 2026 | 16.16 |
| July 27, 2026 | 16.31 |
| July 24, 2026 | 16.31 |
| July 23, 2026 | 16.39 |
| July 22, 2026 | 16.62 |
| July 21, 2026 | 16.91 |
| Date | Value |
|---|---|
| July 20, 2026 | 16.71 |
| July 17, 2026 | 16.42 |
| July 16, 2026 | 15.96 |
| July 15, 2026 | 16.13 |
| July 14, 2026 | 16.01 |
| July 13, 2026 | 15.89 |
| July 10, 2026 | 15.73 |
| July 09, 2026 | 15.83 |
| July 08, 2026 | 15.68 |
| July 07, 2026 | 15.67 |
| July 06, 2026 | 15.72 |
| July 02, 2026 | 15.82 |
| July 01, 2026 | 15.94 |
| June 30, 2026 | 16.00 |
| June 29, 2026 | 16.06 |
| June 26, 2026 | 16.00 |
| June 25, 2026 | 15.71 |
| June 24, 2026 | 15.92 |
| June 23, 2026 | 15.70 |
| June 22, 2026 | 15.93 |
| June 18, 2026 | 15.97 |
| June 17, 2026 | 15.92 |
| June 16, 2026 | 15.90 |
| June 15, 2026 | 15.90 |
| June 12, 2026 | 15.92 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Q32 Bio, Inc. | 16.36 |
| Beam Therapeutics, Inc. | 28.33 |
| C4 Therapeutics, Inc. | 4.10 |
| Cullinan Therapeutics, Inc. | 21.82 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |